What other stocks do shareholders of (RCPT) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (RCPT) investors own include Omeros (OMER) , Esperion Therapeutics (ESPR) , Regeneron Pharmaceuticals (REGN) , Gilead Sciences (GILD) , Intercept Pharmaceuticals (ICPT) , bluebird bio (BLUE) , OPKO Health (OPK) , Vertex Pharmaceuticals (VRTX) and Agios Pharmaceuticals (AGIO) .

NASDAQ:RCPT

(RCPT) (RCPT) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free RCPT Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (RCPT) alerts:

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About (RCPT) Stock (NASDAQ:RCPT)

Receptos, Inc. (Receptos) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics in immune disorders. Its product candidates span three disease areas. It is developing its lead asset, ozanimod (formerly RPC1063), as an oral therapy for the treatment of Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD), which consists of Ulcerative Colitis (UC) and Crohn’s Disease (CD). It is developing its second asset, RPC4046, for the treatment of an allergic/immune-mediated disorder, Eosinophilic Esophagitis (EoE), for which it has been granted Orphan drug designation. Its research efforts include a preclinical program developing oral, small molecule, positive allosteric modulators (PAMs) of the glucagon-like peptide-1 receptor (GLP-1R) for the treatment of Type 2 Diabetes.

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

RCPT Stock News Headlines

November 6, 2023 | msn.com

Police searching for east Tulsa nightclub shooting suspect

October 22, 2023 | msn.com

World champion Leigh Wood confirms next career move with social media post

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 14, 2023 | msn.com

Dramatic Change In Weather Pattern Could Bring Some Snow To Parts Of Northeast

April 4, 2023 | msn.com

One killed in train accident near The Hague, 30 injured

March 28, 2023 | thestreet.com

Receptos (RCPT) Stock Surging on $7.2 Billion Takeover Deal

March 9, 2023 | msn.com

All disabled Root of Nightmare weapons, mods, and gear in Destiny 2’s World First race and Contest Mode

March 9, 2023 | msn.com

World Kidney Day holds special meaning to Winterport kid who was on a donor list for eight hours

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 16, 2023 | msn.com

Indian Railways cancels 443 trains today; complete list of trains cancelled, diverted on 17 February 2023

February 15, 2023 | msn.com

Indian Railways cancels over 450 trains today: Complete list of trains cancelled, diverted by on 15 February 2023

February 3, 2023 | msn.com

Indian Railways cancels 323 trains today: Complete list of trains cancelled, diverted on 4 February, 2023

January 25, 2023 | thestreet.com

Jim Cramer's Top Stock Picks: NVAX TGT BMRN RCPT

January 17, 2023 | msn.com

Will the Doomsday Clock Move Closer to Midnight? Watch Live Online

December 19, 2022 | msn.com

TV and Streaming Viewing Picks for December 19, 2022: how to watch Monday Night Football

October 29, 2022 | msn.com

Toddlers to get free vaccines

September 29, 2022 | msn.com

The row over plans to transform part of a historic castle estate into apartments

September 15, 2022 | msn.com

‘It’d be a huge deal’: NCAA visits Sacramento amid Women’s Final Four bidding

September 15, 2022 | msn.com

Think history class is boring? You haven't been in Mr. Flint's class at Westside High School

August 8, 2022 | msn.com

Beth Dobbin says relay bronze for Scotland 'bittersweet' after England disqualification

July 18, 2022 | benzinga.com

SPCG PCL NON-VTG DEP RCPT by SPCG Public Co Ltd (OTC:SPCGF), Guidance and Forecast

July 18, 2022 | benzinga.com

SPCG PCL NON-VTG DEP RCPT by SPCG Public Co Ltd (OTC:SPCGF), Analyst Ratings, Price Targets, Predictions

July 4, 2022 | thestreet.com

Jim Cramer's Top Stock Picks: CLH, RCPT, MNST, ROST

July 3, 2022 | thestreet.com

Jim Cramer's 'Mad Money' Recap: We're Not Out of the Woods Yet

June 16, 2022 | msn.com

How to Set Up a Postfix Mail Server on Debian

February 20, 2022 | techrepublic.com

Resolving mail server problems with Nslookup and Telnet

See More Headlines

Receive RCPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (RCPT) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:RCPT
CUSIP: N/A
CIK: 1463729
Web: receptos.com
Phone: +1-858-6525700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

RCPT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (RCPT) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (RCPT) investors own include Omeros (OMER), Esperion Therapeutics (ESPR), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), bluebird bio (BLUE), OPKO Health (OPK), Vertex Pharmaceuticals (VRTX) and Agios Pharmaceuticals (AGIO).

This page (NASDAQ:RCPT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(RCPT) (RCPT) Stock Price, News & Analysis

About (RCPT) Stock (NASDAQ:RCPT)

RCPT Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

RCPT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info